Genetics of immunological and inflammatory components in age-related macular degeneration

Ocular Immunology and Inflammation

Volumn 20, Issue 1, 2012, Pages 27-36

  Tuo, Jingsheng ^a   Grob, Seanna ^b   Zhang, Kang ^b   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age related macular degeneration (AMD); Complement factor; Cytokine chemokine; Gene; Innate immunity

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; COPPER; MICRORNA; VERTEPORFIN; ZINC;

ARTICLE; CHROMOSOME ANALYSIS; DRUG MEGADOSE; EPIGENETICS; ETHNICITY; GENE; GENE DOSAGE; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL GENE; NONHUMAN; PHARMACOGENETICS; PHOTODYNAMIC THERAPY; PROPHYLAXIS; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM;

COMPLEMENT SYSTEM PROTEINS; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MACULAR DEGENERATION; MORBIDITY; WORLD HEALTH;

EID: 84856918255     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2011.628432     Document Type: Article

References (119)

1. Penfold PL, Killingsworth MC, Sarks SH: Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol. 1985;223:69-76. (Pubitemid 15051681)
2. Anderson DH, Radeke MJ, Gallo NB et al: The pivotal role of the complement system in aging and age-related macu-lar degeneration: hypothesis re-visited. Prog Retin Eye Res. 2010;29:95-112.
3. Ding X, Patel M, Chan CC: Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2008;28:1-18.
4. Patel M, Chan CC: Immunopathological aspects of age-related macular degeneration. Semin Immunopathol. 2008;30:97-110.
5. Crabb JW, Miyagi M, Gu X et al: Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:14682-14687. (Pubitemid 35334544)
6. Wang L, Clark ME, Crossman DK et al: Abundant lipid and protein components of drusen. PLoS One. 2010;5:e10329.
7. Hollyfeld JG, Salomon RG, Crabb JW: Proteomic approaches to understanding age-related macular degeneration. Adv Exp Med Biol. 2003;533:83-89. (Pubitemid 38005267)
8. Mullins RF, Hageman GS: Human ocular drusen possess novel core domains with a distinct carbohydrate composition. J Histochem Cytochem. 1999;47:1533-1540.
9. West XZ, Malinin NL, Merkulova AA et al: Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature. 2010;467:972-976.
10. Majewski J, Schultz DW, Weleber RG et al: Age-Related Macular Degeneration-a Genome Scan in Extended Families. Am J Hum Genet. 2003;73:540-550. (Pubitemid 37076268)
11. Seddon JM, Santangelo SL, Book K, Chong S, Cote J: A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet. 2003;73:780-790. (Pubitemid 37271882)
12. Weeks DE, Conley YP, Tsai HJ et al: Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet. 2004;75:174-189. (Pubitemid 38943862)
13. Dewan A, Liu M, Hartman S et al: HTRA1 promoter polymorphism in wet age-related macular degeneration. Science. 2006;314:989-992. (Pubitemid 44749943)
14. Edwards AO, Ritter IR, Abel KJ et al: Complement Factor H Polymorphism and Age-Related Macular Degeneration. Science. 2005;308:421-424. (Pubitemid 40530082)
15. Hageman GS, Anderson DH, Johnson LV et al: A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:7227-7232. (Pubitemid 40696361)
16. Haines JL, Hauser MA, Schmidt S et al: Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421. (Pubitemid 40530081)
17. Klein RJ, Zeiss C, Chew EY et al: Complement Factor H Polymorphism in Age-Related Macular Degeneration. Science. 2005;308:385-389. (Pubitemid 40530070)
18. Rivera A, Fisher SA, Fritsche LG et al: Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005;14:3227-3236. (Pubitemid 41631297)
19. Yang Z, Stratton C, Francis PJ et al: Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N Engl J Med. 2008;359:1456-1463.
20. Ryu E, Fridley BL, Tosakulwong N, Bailey KR, Edwards AO: Genome-wide association analyses of genetic, phenotypic, and environmental risks in the age-related eye disease study. Mol Vis. 2010;16:2811-2821.
21. Li Y, Huang D, Xia X et al: CCR3 and choroidal neovascular-ization. PLoS One. 2011;6:e17106.
22. Cho Y, Wang JJ, Chew EY et al: Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples. Invest Ophthalmol Vis Sci. 2009.
23. Weeks DE, Conley YP, Mah TS et al: A full genome scan for age-related maculopathy. Hum Mol Genet. 2000;9:1329-1349. (Pubitemid 30312482)
24. Klein ML, Schultz DW, Edwards A et al: Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol. 1998;116:1082-1088. (Pubitemid 29101833)
25. Dosso AA, Bovet J: Monozygotic twin brothers with age-related macular degeneration. Ophthalmologica. 1992; 205:24-28.
26. Schick JH, Iyengar SK, Klein BE et al: A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. Am J Hum Genet. 2003;72:1412-1424. (Pubitemid 36628381)
27. Iyengar SK, Song D, Klein BE et al: Dissection of genom-ewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet. 2004;74:20-39. (Pubitemid 38085235)
28. Abecasis GR, Yashar BM, Zhao Y et al: Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet. 2004;74:482-494. (Pubitemid 38325919)
29. Weeks DE, Conley YP, Tsai HJ et al: Age-related macul-opathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. Am J Ophthalmol. 2001;132:682-692. (Pubitemid 33031284)
30. Spencer KL, Olson LM, Schnetz-Boutaud N et al: Dissection of chromosome 16p12 linkage peak suggests a possible role for CACNG3 variants in age-related macular degeneration susceptibility. Invest Ophthalmol Vis Sci. 2011;52:1748-1754.
31. Kopplin LJ, Igo RP, Jr., Wang Y et al: Genome-wide association identifes SKIV2L and MYRIP as protective factors for age-related macular degeneration. Genes Immun. 2010;11:609-621.
32. Chen W, Stambolian D, Edwards AO et al: Genetic variants near TIMP3 and high-density lipoprotein-associated loci infuence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA. 2010;107:7401-7406.
33. Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U: Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet. 1994;8:352-356. (Pubitemid 24375600)
34. Zareparsi S, Branham KE, Li M et al: Strong Association of the Y402H Variant in Complement Factor H at 1q32 with Susceptibility to Age-Related Macular Degeneration. Am J Hum Genet. 2005;77:149-153. (Pubitemid 40848046)
35. Yu Z, Brodsky B, Inouye M: Dissecting a bacterial collagen domain from Streptococcus pyogenes: sequence and length-dependent variations in triple helix stability and folding. J Biol Chem. 2011;286:18960-18968.
36. Francis PJ, Schultz DW, Hamon S et al: Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS One. 2007;2:e1197.
37. Li M, Atmaca-Sonmez P, Othman M et al: CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet. 2006;38:1049-1054. (Pubitemid 44325931)
38. Hughes AE, Orr N, Esfandiary H et al: A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet. 2006;38:1173-1177. (Pubitemid 44470363)
39. Mullins RF, Russell SR, Anderson DH, Hageman GS: Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000;14:835-846. (Pubitemid 30241660)
40. Anderson DH, Talaga KC, Rivest AJ et al: Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res. 2004;78:243-256. (Pubitemid 38077231)
41. Nozaki M, Raisler BJ, Sakurai E et al: Drusen complement components C3a and C5a promote choroidal neovasculari-zation. Proc Natl Acad Sci USA. 2006;103:2328-2333. (Pubitemid 43271669)
42. Gold B, Merriam JE, Zernant J et al: Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. NatGenet. 2006;38: 458-462.
43. Maller J, George S, Purcell S et al: Common variation in three genes, including a noncoding variant in CFH, strongly infu-ences risk of age-related macular degeneration. NatGenet. 2006;38:1055-1059. (Pubitemid 44325932)
44. Spencer KL, Hauser MA, Olson LM et al: Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet. 2007;16:1986-1992. (Pubitemid 47354881)
45. Yates JR, Sepp T, Matharu BK et al: Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med. 2007;357:553-561. (Pubitemid 47236280)
46. Combadiere C, Feumi C, Raoul W et al: CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest. 2007;117:2920-2928. (Pubitemid 47529622)
47. Tuo J, Smith B, Bojanowski CM et al: The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J. 2004;18:1297-1299. (Pubitemid 39561582)
48. Yang X, Hu J, Zhang J, Guan H: Polymorphisms in CFH, HTRA1 and CX3CR1 confer risk to exudative age-related macular degeneration in Han Chinese. Br J Ophthalmol. 2010;94:1211-1214.
49. Zerbib J, Puche N, Richard F et al: No association between the T280M polymorphism of the CX3CR1 gene and exudative AMD. Exp Eye Res. In Press, Corrected Proof.
50. Takeda A, Baff JZ, Kleinman ME et al: CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature. 2009;460:225-230.
51. Chen Y, Bedell M, Zhang K: Age-related macular degeneration: genetic and environmental factors of disease. Mol Interv. 2010;10:271-281.
52. Seitsonen S P, Onkamo P, Peng G et al: Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration. PLoS One. 2008;3:e3833.
53. Schmidt S, Hauser MA, Scott WK et al: Cigarette Smoking Strongly Modifes the Association of LOC387715 and Age-Related Macular Degeneration. Am J Hum Genet. 2006; 78:852-864.
54. Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ: A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifable risk factors. Arch Ophthalmol. 2007;125:55-62. (Pubitemid 46072376)
55. Seddon JM, Reynolds R, Maller J et al: Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009;50:2044-2053.
56. Hughes AE, Orr N, Patterson C et al: Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Med. 2007;4:e355.
57. Nakanishi H, Yamashiro K, Yamada R et al: Joint effect of cigarette smoking and CFH and LOC387715/HTRA1 polymorphisms on polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2010;51:6183-6187.
58. Tuo J, Ross RJ, Reed GF et al: The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples. Ophthalmology. 2008;115:1891-1898.
59. Francis PJ, Hamon SC, Ott J, Weleber RG, Klein ML: Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. J Med Genet. 2009;46:300-307.
60. Conley YP, Jakobsdottir J, Mah T et al: CFH, ELOVL4, PLEKHA1, and LOC387715 genes and susceptibility to Age-Related Maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet. 2006;15:3206-3218. (Pubitemid 44605500)
61. Leveziel N, Souied EH, Richard F et al: PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population. Mol Vis. 2007;13:2153-2159. (Pubitemid 350200532)
62. Kaur I, Katta S, Hussain A et al: Variants in the 10q26 gene cluster (LOC387715 and HTRA1) exhibit enhanced risk of age-related macular degeneration along with CFH in Indian patients. Invest Ophthalmol Vis Sci. 2008;49:1771-1776.
63. Gotoh N, Yamashiro K, Nakanishi H et al: Haplotype analysis of the ARMS2/HTRA1 region in Japanese patients with typical neovascular age-related macular degeneration or polypoidal choroidal vasculopathy. Jpn J Ophthalmol. 2010;54:609-614.
64. Chu J, Zhou CC, Lu N, Zhang X, Dong FT: Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population. Chin Med J (Engl). 2008;121:2525-2533.
65. Sng CC, Cackett PD, Yeo IY et al: Toll-like receptor 3 polymorphism rs3775291 is not associated with choroidal neovascu-larization or polypoidal choroidal vasculopathy in Chinese subjects. Ophthalmic Res. 2011;45:191-196.
66. Conrad DF, Pinto D, Redon R et al: Origins and functional impact of copy number variation in the human genome. Nature. 2010;464:704-712.
67. Redon R, Ishikawa S, Fitch KR et al: Global variation in copy number in the human genome. Nature. 2006;444:444-454. (Pubitemid 44809057)
68. Coin LJ, Asher JE, Walters RG et al: cnvHap: an integrative population and haplotype-based multiplatform model of SNPs and CNVs. Nat Methods. 2010;7:541-546.
69. Zhang F, Gu W, Hurles ME, Lupski JR: Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet. 2009;10:451-481.
70. Aitman TJ, Dong R, Vyse TJ et al: Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature. 2006;439:851-855. (Pubitemid 43255703)
71. Hollox EJ, Huffmeier U, Zeeuwen PL et al: Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet. 2008;40:23-25.
72. Huffmeier U, Bergboer JG, Becker T et al: Replication of LCE3C-LCE3B CNV as a risk factor for psoriasis and analysis of interaction with other genetic risk factors. J Invest Dermatol. 2010;130:979-984.
73. Ptacek T, Li X, Kelley JM, Edberg JC: Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus. Cytogenet Genome Res. 2008;123:142-147.
74. Yang Y, Chung EK, Wu YL et al: Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet. 2007;80:1037-1054. (Pubitemid 47579341)
75. Willcocks LC, Lyons PA, Clatworthy MR et al: Copy number of FCGR3B, which is associated with systemic lupus erythe-matosus, correlates with protein expression and immune complex uptake. J Exp Med. 2008;205:1573-1582. (Pubitemid 351962021)
76. Liu S, Yao L, Ding D, Zhu H: CCL3L1 copy number variation and susceptibility to HIV-1 infection: a meta-analysis. PLoS One. 2010;5:e15778.
77. Meyer KJ, Davis LK, Schindler EI et al: Genome-wide analysis of copy number variants in age-related macular degeneration. Hum Genet. 2011;129:91-100.
78. Jiang ST, Chiou YY, Wang E et al: Essential role of neph-rocystin in photoreceptor intrafagellar transport in mouse. Hum Mol Genet. 2009;18:1566-1577.
79. Fu L, Garland D, Yang Z et al: The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum Mol Genet. 2007;16:2411-2422. (Pubitemid 47500628)
80. Narendran N, Guymer RH, Cain M, Baird PN: Analysis of the EFEMP1 gene in individuals and families with early onset drusen. Eye (Lond). 2005;19:11-15. (Pubitemid 40192631)
81. Hageman GS, Hancox LS, Taiber AJ et al: Extended haplo-types in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med. 2006;38:592-604. (Pubitemid 46292019)
82. Schmid-Kubista KE, Tosakulwong N, Wu Y et al: Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009;50:5070-5079.
83. Fritsche LG, Lauer N, Hartmann A et al: An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H infuences risk for age-related macular degeneration (AMD). Hum Mol Genet. 2010;19:4694-4704.
84. Klein R, Klein BE, Knudtson MD et al: Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 2006;113:373-380.
85. Polymeropoulos MH, Lavedan C, Leroy E et al: Mutation in the alpha-synuclein gene identifed in families with Parkinson's disease. Science. 1997;276:2045-2047. (Pubitemid 27443610)
86. Singleton AB, Farrer M, Johnson J et al: alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003;302:841. (Pubitemid 37339619)
87. Hinds DA, Kloek AP, Jen M, Chen X, Frazer KA: Common deletions and SNPs are in linkage disequilibrium in the human genome. Nat Genet. 2006;38:82-85. (Pubitemid 43011886)
88. Liu MM, Agron E, Chew E et al: Copy Number Variations in Candidate Genes in Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2011.
89. Bressler SB, Munoz B, Solomon SD, West SK: Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project. Arch Ophthalmol. 2008;126:241-245. (Pubitemid 351240854)
90. Tuo J, Bojanowski CM, Zhou M et al: Murine ccl2/cx3cr1 defciency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007;48:3827-3836. (Pubitemid 351261124)
91. Age-Related Eye Disease Study Research G: A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.
92. Smith TC, Lee L: Age related macular degeneration-new developments in treatment. Aust Fam Physician 2007; 36:359-361.
93. Parmeggiani F, Costagliola C, Gemmati D et al: Coagulation gene predictors of photodynamic therapy for occult choroi-dal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:3100-3106.
94. Parmeggiani F, Costagliola C, Gemmati D et al: Predictive role of coagulation-balance gene polymorphisms in the effcacy of photodynamic therapy with verteporfn for classic choroidal neovascularization secondary to age-related macular degeneration. Pharmacogenet Genomics. 2007;17:1039-1046. (Pubitemid 351339488)
95. Parmeggiani F, Gemmati D, Costagliola C, Sebastiani A, Incorvaia C: Predictive role of C677T MTHFR polymorphism in variable effcacy of photodynamic therapy for neovas-cular age-related macular degeneration. Pharmacogenomics. 2009;10:81-95.
96. Lee AY, Raya AK, Kymes SM, Shiels A, Brantley MA, Jr.: Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab. Br J Ophthalmol. 2009;93:610-613.
97. Lee AY, Brantley MA, Jr.: CFH and LOC387715/ARMS2 genotypes and antioxidants and zinc therapy for age-related macular degeneration. Pharmacogenomics. 2008;9:1547-1550.
98. Klein ML, Francis PJ, Rosner B et al: CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology. 2008;115:1019-1025.
99. Brantley MA, Jr., Fang AM, King JM et al: Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravit-real bevacizumab. Ophthalmology. 2007;114:2168-2173. (Pubitemid 350181136)
100. Nischler C, Oberkofer H, Ortner C et al: Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration. Acta Ophthalmol. 2011;89:344-349.
101. Blom AM, Kask L, Ramesh B, Hillarp A: Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H. Arch Biochem Biophys. 2003;418:108-118. (Pubitemid 37159377)
102. Goverdhan SV, Hannan S, Newsom RB et al: An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment. Eye (Lond). 2008;22:849-854. (Pubitemid 351850525)
103. Neale BM, Fagerness J, Reynolds R et al: Genome-wide association study of advanced age-related macular degeneration identifes a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA. 2010;107:7395-7400.
104. Seitsonen SP, Jarvela IE, Meri S et al: The effect of complement factor H Y402H polymorphism on the outcome of photodynamic therapy in age-related macular degeneration. Eur J Ophthalmol. 2007;17:943-949. (Pubitemid 351262905)
105. Brantley MA, Jr., Edelstein SL, King JM et al: Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy. Eye (Lond). 2009;23:626-631.
106. McKibbin M, Ali M, Bansal S et al: CFH, VEGF and HTRA1 promoter genotype may infuence the response to intravit-real ranibizumab therapy for neovascular age-related macu-lar degeneration. Br J Ophthalmol. 2011.
107. Cho Y, Cao X, Shen D et al: Evidence for enhanced tissue factor expression in age-related macular degeneration. Lab Invest. 2011;91:519-526.
108. Bell CG, Beck S: The epigenomic interface between genome and environment in common complex diseases. Brief Funct Genomics. 2010;9:477-485.
109. Fernandez-Morera JL, Calvanese V, Rodriguez-Rodero S, Menendez-Torre E, Fraga MF: Epigenetic regulation of the immune system in health and disease. Tissue Antigens. 2010;76:431-439.
110. Bentwich I, Avniel A, Karov Y et al: Identifcation of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005;37:766-770. (Pubitemid 41754896)
111. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D: Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010;10:111-122.
112. Kutty RK, Nagineni CN, Samuel W et al: Infammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway. Biochem Biophys Res Commun. 2010;402: 390-395.
113. Kaneko H, Dridi S, Tarallo V et al: DICER1 defcit induces Alu RNA toxicity in age-related macular degeneration. Nature 2011;471:325-330.
114. Damiani D, Alexander JJ, O'Rourke JR et al: Dicer inac-tivation leads to progressive functional and structural degeneration of the mouse retina. J Neurosci. 2008;28: 4878-4887.
115. Zhou Q, Gallagher R, Ufret-Vincenty R et al: Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters. Proc Natl Acad Sci USA. 2011;108:8287-8292.
116. Baas DC, Ho L, Ennis S et al: The complement component 5 gene and age-related macular degeneration. Ophthalmology. 2010;117:500-511.
117. Goverdhan SV, Howell MW, Mullins RF et al: Association of HLA class I and class II polymorphisms with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2005;46:1726-1734. (Pubitemid 44843610)
118. Despriet DD, Bergen AA, Merriam JE et al: Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:364-371.
119. Kaur I, Hussain A, Hussain N et al: Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47:3729-3735. (Pubitemid 46044283)